Expression of Vascular Endothelial Growth Factor (VEGF) in Macrophages, Fibroblasts, and Endothelial Cells in Pterygium Treated with 5-Fluorouracil

References

• Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review). Int J Mol Med 2009;23(4):439–447
   PubMed Web of Science ®Google Scholar
• Solomon AS. Pterygium. Br J Ophthalmol 2006;90:665–666
   PubMedGoogle Scholar
• Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006;47:2430–2437
   PubMed Web of Science ®Google Scholar
• Coroneo MT. Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol 1993;77:734–739
   PubMed Web of Science ®Google Scholar
• Lee DH, Cho HJ, Kim JT, et al. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001;20:738–742
   PubMed Web of Science ®Google Scholar
• Jin J, Guan M, Sima J, et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 2003;22:473–477
   PubMed Web of Science ®Google Scholar
• Lee JK, Song YS, Ha HS, et al. Endothelial progenitor cells in pterygium pathogenesis. Eye 2007;21:1186–1193
   PubMed Web of Science ®Google Scholar
• Schellini SA, Hoyama E, Oliveira DE, et al. Matrix metalloproteinase-9 expression in pterygium. Arq Bras Oftalmol 2006;69:161–164
   Google Scholar
• Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 2000;41:4142–4149
   PubMed Web of Science ®Google Scholar
• Di Girolamo N, McCluskey P, Lloyd A, et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000;41:671–679
   PubMed Web of Science ®Google Scholar
• Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999;10:282–288
   PubMedGoogle Scholar
• Marcovich AL, Morad Y, Sandbank J, et al. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 2002;25(1):17–22
   Google Scholar
• Aspiotis M, Tsanou E, Gorezis S, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and trombospondin-1. Eye 2007;21:1095–1101
   PubMed Web of Science ®Google Scholar
• Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998;236:702–708
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang M, Li X, et al. Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium. J Huazhong Univ Sci Technolog Med Sci 2011;31(4):560–564
   Google Scholar
• Park CY, Choi JS, Lee SJ, et al. Cycloxigenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Mol Vision 2011;17:3468–3480
   PubMed Web of Science ®Google Scholar
• Bianchi E, Scarinci F, Grande C, et al. Immunohistochemical profile of VEGF, TGF-β and PGE2 in human pterygium and normal conjunctiva: experimental study and review of the literature. Int J Immunopathol Pharmacol 2012;25(3):607–615
   Google Scholar
• Liang K, Jiang Z, Zhao B, et al. The expression of vascular endothelial growth factor in mast cells promotes the neovascularization of human pterygia. Br J Ophthalmol 2012;96(9):1246–1251
   PubMed Web of Science ®Google Scholar
• Khalfaoui T, Mkannez G, Colin D, et al. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and P53 expression in pterygium from Tunisian patients. Pathologie Biologie 2011;59:137–141
   Google Scholar
• Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984;98:225–228
   PubMed Web of Science ®Google Scholar
• Ooyama A, Oka T, Zhao HY, et al. Anti-angiogenic effect of 5-fluorouracil-based drugs against human colon cancer xenografts. Cancer Lett 2008;267(1):26–36
   Google Scholar
• Viveiros MM, Schellini SA, Candeias J, et al. Exposure of normal Tenon's capsule fibroblasts from pterygium to 5-fluorouracil and mitomycin C. Arq Bras Oftalmol 2007;70(1):73–77
   Google Scholar
• Kim I, Ryan AM, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 1999;40:2115–2121
   PubMed Web of Science ®Google Scholar
• Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998;39:18–22
   PubMed Web of Science ®Google Scholar
• Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457–10461
   PubMed Web of Science ®Google Scholar
• Detorakis ET, Zaravinos A, Spandidos DA. Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med. 2010;25:513–516
   PubMedGoogle Scholar
• Cilova-Atanasova B. The mastocyte reaction in pterygium. Folia Med (Plovdiv) 1971;13:21–26
   Google Scholar
• Dushku N, John MK, Schultz GS, Reid TW. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 2001;119:695–706
   PubMed Web of Science ®Google Scholar
• Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem 1996;98:195–201
   PubMed Web of Science ®Google Scholar
• Gebhardt M, Mentlein R, Schaudig U, et al. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. Ophthalmol 2005;112(6):1023–1030
   Google Scholar
• Wada H, Nagano H, Yamamoto H, et al. Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells. BMC Cancer 2009;12(9):361–369
   Google Scholar
• Matsushita S, Ikeda R, Nishizawa Y, et al. The role of thymidine phosphorylase in the induction of early growth response protein-1 and trombospondin-1 by 5-fluorouracil in humn cancer carcinoma cells. Int J Oncol 2010;36(5):1193–1200
   Google Scholar